|
|
Volumn 86, Issue 11, 2002, Pages 1684-1690
|
|
Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
a,d
a
|
|
Author keywords
Chemotherapy; Colorectal cancer; Costs
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
RALTITREXED;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
FEMALE;
HEALTH CARE COST;
HOSPITAL ADMISSION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
COSTS AND COST ANALYSIS;
FEMALE;
GREAT BRITAIN;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
|
|
EID: 0037024433
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6600273 Document Type: Article |
|
Times cited : (21)
|
|
References (10)
|
